Comprehensive molecular characterization of gastric adenocarcinoma
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein–Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roadmap for patient stratification and trials of targeted therapies. The Cancer Genome Atlas reports on molecular evaluation of 295 primary gastric adenocarcinomas and proposes a new classification of gastric cancers into 4 subtypes, which should help with clinical assessment and trials of targeted therapies. This contribution from The Cancer Genome Atlas (TCGA) project describes the molecular evaluation of 295 primary gastric adenocarcinomas. Based on the results, the authors propose a novel classification separating gastric cancers into four subtypes according to: Epstein–Barr virus positive status, microsatellite instability, chromosomal instability or genomic stability. Given the histologic and etiologic heterogeneity of gastric cancer identification of these subtypes, using a schema that can readily be applied to patient samples should help with patient stratification and trials of targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the miRNAs were also reported by a recent systems biology paper from TCGA in 2014 [34].”
From Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets (2015) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The fusion of this evidence has prompted TCGA and the Asian Cancer Research Group (ACRG) to propose several molecular classifications [77,78].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“The TP53/APC double knockout (DKO) organoid line was established in our previous studies by sequentially disrupting TP53 and APC37, two common oncogenic loci in gastric adenocarcinoma38,39, from non-neoplastic human gastric organoids (Fig. S1A).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [38]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fusobacterium spp. is important in the development and progression of gastrointestinal tumors1,19,34,35”
From RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach (2020) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Self-citationLAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationWHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Cell Migration: Integrating Signals from Front to Back
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T., & Horwitz, A. R. (2003) · Science · doi:10.1126/science.1092053 · Cited by 4,978
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Research works printed but not linked: 2
- Ferlay, J. et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase 11, http://globocan.iarc.fr, accessed on January 15, 2014 (2013)
- The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012) · DOI · Paper page
Cited by
Items 401–500 of 1,024
Kelly, R. J., Lee, J., Bang, Y., Almhanna, K., Blum-Murphy, M. A., Catenacci, D. V. T., Chung, H. C., Wainberg, Z. A., Gibson, M. K., Lee, K., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2443 · Cited by 144
The Long Noncoding RNA CCAT2 Induces Chromosomal Instability Through BOP1-AURKB Signaling
Chen, B., Dragomir, M. P., Fabris, L., Bayraktar, R., Knutsen, E., Liu, X., Tang, C., Li, Y., Shimura, T., Ivković, T. C., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.08.018 · Cited by 140
Helsten, T. L., Schwaederle, M. C., & Kurzrock, R. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9579-8 · Cited by 135
Riquelme, I., Tapia, Ó., Leal, P., Sandoval, A., Varga, M. G., Letelier, P. J., Buchegger, K., Bizama, C., Espinoza, J. A., Peek, R. M., et al. (2015) · Cellular Oncology · doi:10.1007/s13402-015-0247-3 · Cited by 132
Frequent BCOR aberrations in extranodal NK/T ‐Cell lymphoma, nasal type
Dobashi, A., Tsuyama, N., Asaka, R., Togashi, Y., Ueda, K., Sakata, S., Baba, S., Sakamoto, K., Hatake, K., & Takeuchi, K. (2016) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22348 · Cited by 144
Coati, I., Lotz, G., Fanelli, G. N., Brignola, S., Lanza, C., Cappellesso, R., Pellino, A., Pucciarelli, S., Spolverato, G., Guzzardo, V., et al. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0508-4 · Cited by 131
Giraud, J., Molina‐Castro, S., Seeneevassen, L., Sifré, E., Izotte, J., Tiffon, C., Staedel, C., Bœuf, H., Fernandez, S., Barthélémy, P., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32667 · Cited by 143
Chen, W., Huang, M., Sun, D.-P., Kong, R., Xu, T., Xia, R., Zhang, E., & Shu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.6949 · Cited by 130
Molecular subtypes in cancers of the gastrointestinal tract
Bijlsma, M. F., Sadanandam, A., Tan, P. B. O., & Vermeulen, L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.33 · Cited by 150
Kato, S., Okamura, R., Baumgartner, J. M., Patel, H., Leichman, L., Kelly, K. J., Sicklick, J. K., Fanta, P. T., Lippman, S. M., & Kurzrock, R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1128 · Cited by 130
Bure, I. V., Nemtsova, M. V., & Zaletaev, D. V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122870 · Cited by 138
Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy
Gilson, P., Merlin, J., & Harlé, A. (2022) · Cancers · doi:10.3390/cancers14061384 · Cited by 158
Conditional Selection of Genomic Alterations Dictates Cancer Evolution and Oncogenic Dependencies
Mina, M., Raynaud, F., Tavernari, D., Battistello, E., Sungalee, S., Saghafinia, S., Laessle, T., Sanchez-Vega, F., Schultz, N., Oricchio, E., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.010 · Cited by 129
Self-citationInsertions and Deletions Target Lineage-Defining Genes in Human Cancers
Imielinski, M., Guo, G., & Meyerson, M. (2017) · Cell · doi:10.1016/j.cell.2016.12.025 · Cited by 129
New agents on the horizon in gastric cancer
Lordick, F., Shitara, K., & Janjigian, Y. Y. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx051 · Cited by 131
Schulz, C. U., Kullmann, F., Kunzmann, V., Fuchs, M., Geißler, M., Vehling‐Kaiser, U., Stauder, H., Wein, A., Al‐Batran, S., Kubin, T., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29403 · Cited by 127
Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer
Marrelli, D., Połom, K., Pascale, V., Vindigni, C., Piagnerelli, R., Franco, L. D., Ferrara, F., Roviello, G., Garosi, L., Petrioli, R., et al. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-015-4931-3 · Cited by 128
Analysis of somatic microsatellite indels identifies driver events in human tumors
Maruvka, Y. E., Mouw, K. W., Karlic, R., Parasuraman, P., Kamburov, A., Polak, P., Haradhvala, N. J., Hess, J. M., Rheinbay, E., Brody, Y., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3966 · Cited by 128
A serum exosomal microRNA panel as a potential biomarker test for gastric cancer
Wang, N., Wang, L., Yang, Y., Gong, L., Xiao, B., & Liu, X. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.003 · Cited by 131
Wu, S., Chen, M., Huang, J., Zhang, F., Lv, Z., Jia, Y., Cui, Y., Sun, L.-Z., Wang, Y., Tang, Y., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0049 · Cited by 128
Cao, Y., Xie, L., Shi, F., Tang, M., Li, Y., Hu, J., Zhao, L., Zhao, L., Yu, X., Luo, X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00376-4 · Cited by 137
Verschoor, Y. L., van de Haar, J., van den Berg, J. G., van Sandick, J. W., Kodach, L. L., van Dieren, J. M., Balduzzi, S., Grootscholten, C., Ijsselsteijn, M. E., Veenhof, A. A. F. A., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02758-x · Cited by 158
“4g) 41 , increasing the likelihood that our findings will translate to the general patient population.”
BackgroundBruce, J. P., To, K., Lui, V. W. Y., Chung, G. T. Y., Chan, Y., Tsang, C. M., Yip, K. Y.-L., Ma, B. B. Y., Woo, J. K. S., Hui, E. P., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24348-6 · Cited by 132
Muti, H. S., Heij, L. R., Keller, G., Kohlruss, M., Langer, R., Dislich, B., Cheong, J.-H., Kim, Y.-W., Kim, H., Kook, M.-C., et al. (2021) · The Lancet Digital Health · doi:10.1016/s2589-7500(21)00133-3 · Cited by 126
Xue, Z., Vis, D. J., Bruna, A., Sustic, T., van Wageningen, S., Batra, A. S., Rueda, O. M., Bosdriesz, E., Caldas, C., Wessels, L. F. A., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0044-4 · Cited by 125
Immunotherapy in advanced gastric cancer, is it the future?
Coutzac, C., Pernot, S., Chaput, N., & Zaanan, A. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.10.007 · Cited by 140
Ding, N., Zou, Z., Sha, H., Su, S., Qian, H., Meng, F., Chen, F., Du, S., Zhou, S., Chen, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09296-6 · Cited by 126
Lee, J., Kim, H., Lee, J. E., Shin, S., Oh, S., Kwon, G., Kim, H., Choi, Y. H., White, M. A., Paik, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.024 · Cited by 133
An integrative analysis of the age-associated multi-omic landscape across cancers
Chatsirisupachai, K., Lesluyes, T., Paraoan, L., Van Loo, P., & de Magalhães, J. P. (2021) · Nature Communications · doi:10.1038/s41467-021-22560-y · Cited by 122
Targeted therapies for gastric cancer: failures and hopes from clinical trials
Apicella, M., Corso, S., & Giordano, S. (2017) · Oncotarget · doi:10.18632/oncotarget.14825 · Cited by 134
Epstein–Barr virus in the pathogenesis of oral cancers
Guidry, J. T., Birdwell, C., & Scott, R. S. (2017) · Oral Diseases · doi:10.1111/odi.12656 · Cited by 124
Network-based machine learning and graph theory algorithms for precision oncology
Zhang, W., Chien, J., Yong, J., & Kuang, R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0029-7 · Cited by 124
Maron, S. B., Alpert, L., Kwak, H. A., Lomnicki, S., Chase, L., Xu, D., O'Day, E., Nagy, R. J., Lanman, R. B., Cecchi, F., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1260 · Cited by 124
Distinct molecular subtypes of gastric cancer: from Laurén to molecular pathology
Cisło, M., Filip, A. A., Offerhaus, G. J. A., Ciseł, B., Rawicz‐Pruszyński, K., Skierucha, M., & Polkowski, W. P. (2018) · Oncotarget · doi:10.18632/oncotarget.24827 · Cited by 164
The genomic landscape of Epstein-Barr virus-associated pulmonary lymphoepithelioma-like carcinoma
Hong, S., Liu, D., Luo, S., Fang, W., Zhan, J., Fu, S., Zhang, Y., Wu, X., Zhou, H., Chen, X., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10902-w · Cited by 126
Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations
Flanagan, D. J., Barker, N., Costanzo, N. S. D., Mason, E. A., Gurney, A., Meniel, V. S., Koushyar, S., Austin, C. R., Ernst, M., Pearson, H. B., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2095 · Cited by 122
“Recent large-scale sequencing of human gastric tumors has identified environmental and genetic factors associated with increased pathology, which include aberrant Wnt signaling [48-50].”
BackgroundZhao, Y., Pan, Z., Namburi, S., Pattison, A., Posner, A., Balachander, S., Paisie, C. A., Reddi, H. V., Rueter, J., Gill, A. J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.103030 · Cited by 122
“Such subtyping is growing in clinical relevance and can be used as a predictive marker for therapeutic approaches [69].”
BackgroundBile acids and their receptors in regulation of gut health and diseases
Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 131
Waldum, H. L., & Fossmark, R. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19124109 · Cited by 143
Ji, L., Qian, W., Gui, L., Ji, Z., Yin, P., Lin, G. N., Wang, Y., Ma, B., & Gao, W. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3074 · Cited by 136
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
Cheong, J., Wang, S. C., Park, S., Porembka, M. R., Christie, A. L., Kim, H., Kim, H. S., Zhu, H., Hyung, W. J., Noh, S. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28437-y · Cited by 126
Recent developments in immunotherapy for gastrointestinal tract cancers
Chong, X., Madeti, Y., Cai, J., Li, W., Cong, L., Lu, J., Mo, L., Liu, H., He, S., Yu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01578-x · Cited by 146
Nassar, A. H., Adib, E., Abou Alaiwi, S., El Zarif, T., Groha, S., Akl, E. W., Nuzzo, P. V., Mouhieddine, T. H., Perea-Chamblee, T., Taraszka, K., et al. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.08.022 · Cited by 121
Self-citationThe Impact of Pathway Database Choice on Statistical Enrichment Analysis and Predictive Modeling
Mubeen, S., Hoyt, C. T., Gemünd, A., Hofmann‐Apitius, M., Fröhlich, H., & Domingo‐Fernándéz, D. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01203 · Cited by 143
CDKN2A Alterations and Response to Immunotherapy in Solid Tumors
Adib, E., Nassar, A. H., Akl, E. W., Alaiwi, S. A., Nuzzo, P. V., Mouhieddine, T. H., Sonpavde, G., Haddad, R. I., Mouw, K. W., Giannakis, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0575 · Cited by 131
Preclinical to clinical utility of ROCK inhibitors in cancer
Barcelo, J., Samain, R., & Sanz‐Moreno, V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2022.12.001 · Cited by 145
Epstein–Barr Virus Infection and Gastric Cancer
Chen, X., Chen, H., Castro, F. A., Hu, J., & Brenner, H. (2015) · Medicine · doi:10.1097/md.0000000000000792 · Cited by 120
Li, X., Wu, W. K. K., Xing, R., Wong, S. H., Liu, Y., Fang, X., Zhang, Y., Wang, M., Wang, J., Li, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2443 · Cited by 132
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review
Huang, Y., & Yu, J.-C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i34.9863 · Cited by 124
SOX9 Elevation Acts with Canonical WNT Signaling to Drive Gastric Cancer Progression
Santos, J. C., Carrasco‐García, E., García-Puga, M., Aldaz, P., Montes, M., Fernández‐Reyes, M., de Oliveira, C. C., Lawrie, C. H., Araúzo-Bravo, M. J., Ribeiro, M. L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-1120 · Cited by 130
Chen, Z.-D., Zhang, P., Xi, H., Wei, B., Chen, L., & Tang, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.744839 · Cited by 120
“The Cancer Genome Atlas (TCGA) network classified gastric cancer into four subtypes: Chromosomal instability (CIN), microsatellite instable (MSI) tumors, genomically stable (GS) tumors, and Epstein-Barr virus (EBV)-positive tumors (37).”
BackgroundInfluentialIntegration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
Gwee, Y. X., Chia, D. K. A., So, J. B. Y., Ceelen, W. P., Yong, W. P., Tan, P. B. O., Ong, C. J., & Sundar, R. (2022) · Journal of Clinical Oncology · doi:10.1200/jco.21.02745 · Cited by 124
Zuo, Q.-F., Cao, L.-Y., Yu, T., Gong, L., Wang, L.-N., Zhao, Y.-L., Xiao, B., & Zou, Q.-M. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.297 · Cited by 123
Variegated RHOA mutations in adult T-cell leukemia/lymphoma
Nagata, Y., Kontani, K., Enami, T., Kataoka, K., Ishii, R., Totoki, Y., Kataoka, T. R., Hirata, M., Aoki, K., Nakano, K., et al. (2016) · Blood · doi:10.1182/blood-2015-06-644948 · Cited by 118
A global burden of gastric cancer: the major impact of China
Nie, Y., Wu, K., Yu, J. Q., Liang, Q., Cai, X., Shang, Y., Zhou, J., Pan, K., Sun, L. L., Fang, J., et al. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2017.1312342 · Cited by 131
“Recently, the Cancer Genome Atlas Research Network identified a comprehensive molecular classification that divides GC into four subtypes: tumors positive for Epstein– Barr virus (EBV), microsatellite unstable tumors, genomically stable tumors, and tumors with chromosomal instability [5].”
BackgroundInfluentialARID1A Mutations Are Associated with Increased Immune Activity in Gastrointestinal Cancer
Li, L., Li, M., Jiang, Z., & Wang, X. (2019) · Cells · doi:10.3390/cells8070678 · Cited by 126
ACTL6A protects gastric cancer cells against ferroptosis through induction of glutathione synthesis
Yang, Z., Zou, S., Zhang, Y., Zhang, J., Zhang, P., Xiao, L., Xie, Y., Meng, M., Feng, J., Kang, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39901-8 · Cited by 137
Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
Hayakawa, Y., Sethi, N. S., Sepulveda, A. R., Bass, A. J., & Wang, T. C. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.24 · Cited by 134
Gastric cancer in FAP: a concerning rise in incidence
Mankaney, G., Leone, P. J., Cruise, M. W., Laguardia, L. A., O’Malley, M., Bhatt, A., Church, J. M., & Burke, C. A. (2017) · Familial Cancer · doi:10.1007/s10689-017-9971-3 · Cited by 121
Hagen, S. J., Ang, L., Zheng, Y. Z., Karahan, S. N., Wu, J., Wang, Y. E., Caron, T. J., Gad, A. P., Muthupalani, S., & Fox, J. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.08.041 · Cited by 118
Chun, H.-J. E., Johann, P. D., Milne, K., Zapatka, M., Büllesbach, A., Ishaque, N., Iskar, M., Erkek, S., Wei, L. L., Tessier‐Cloutier, B., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.013 · Cited by 124
“Cancer Genome Atlas Research Network (2014a).”
MethodInfluentialJiang, H., Yu, X., Li, N., Kong, M., Ma, Z.-M., Zhou, D., Wang, W., Wang, H., Wang, H., He, K., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003635 · Cited by 128
Mediator kinase module and human tumorigenesis
Clark, A. D., Oldenbroek, M., & Boyer, T. (2015) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2015.1064854 · Cited by 131
Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
Inoue, Y., Yoshimura, K., Mori, K., Kurabe, N., Kahyo, T., Mori, H., Kawase, A., Tanahashi, M., Ogawa, H., Inui, N., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8528 · Cited by 121
Risk factors predisposing to cardia gastric adenocarcinoma: Insights and new perspectives
Abdi, E., Latifi‐Navid, S., Zahri, S., Yazdanbod, A., & Pourfarzi, F. (2019) · Cancer Medicine · doi:10.1002/cam4.2497 · Cited by 126
Yuan, Q., Deng, D., Chen, P., Ren, J., Wei, T., Wu, Z., Zhang, B., Li, S., Yin, P., & Shang, D. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.951137 · Cited by 127
MEK and PI3K inhibition in solid tumors: rationale and evidence to date
Jokinen, E., & Koivunen, J. P. (2015) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015571111 · Cited by 116
Ahn, S., Lee, J., Hong, M., Sk, K., Park, S. H., Choi, M. G., Lee, J. H., Sohn, T. S., Bae, J. M., Sk, K., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.96 · Cited by 122
Long, J., Lin, J., Wang, A., Wu, L., Zheng, Y., Yang, X., Wan, X., Xu, H., Chen, S., & Zhao, H. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0511-2 · Cited by 116
Gastric Cancer in the Era of Precision Medicine
Liu, X., & Meltzer, S. J. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.02.003 · Cited by 135
Masuda, K., & Kuwano, Y. (2018) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1520 · Cited by 124
Risk of gastric cancer in the second decade of follow-up after Helicobacter pylori eradication
Take, S., Mizuno, M., Ishiki, K., Kusumoto, C., Imada, T., Hamada, F., Yoshida, T., Yokota, K., Mitsuhashi, T., & Okada, H. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01639-w · Cited by 115
The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress
Bauer, M., Naščáková, Z., Mihai, A.-I., Cheng, P. F., Levesque, M. P., Lampart, S., HURWITZ, R. M., Pfannkuch, L., Dobrovolná, J., Jacobs, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18857-z · Cited by 129
Lee, H., Palm, J., Grimes, S. M., & Ji, H. P. (2015) · Genome Medicine · doi:10.1186/s13073-015-0226-3 · Cited by 115
A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline
Liu, X., Zheng, W., Wang, W., Shen, H., Liu, L., Lou, W., Wang, X., & Yang, P. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.365 · Cited by 119
Cai, H., Jing, C., Chang, X., Ding, D., Han, T., Yang, J., Lu, Z., Hu, X., Liu, Z., Wang, J., et al. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1941-0 · Cited by 119
Pernot, S., Terme, M., Radosevic‐Robin, N., Castan, F., Badoual, C., Marcheteau, E., Penault-Llorca, F. M., Bouché, O., Bennouna, J., François, É., et al. (2019) · Gastric Cancer · doi:10.1007/s10120-019-00983-3 · Cited by 123
Targeting Wnts at the Source—New Mechanisms, New Biomarkers, New Drugs
Madan, B., & Virshup, D. M. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-1038 · Cited by 114
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
Hempelmann, J. A., Lockwood, C. M., Konnick, E. Q., Schweizer, M. T., Antonarakis, E. S., Lotan, T. L., Montgomery, B., Nelson, P. S., Klemfuss, N. M., Salipante, S. J., et al. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0341-y · Cited by 123
Zhang, J., Zhou, Y., Huang, T., Wu, F., Liu, L., Kwan, J. S. H., Cheng, A. S. L., Yu, J., To, K. F., & Kang, W. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22831 · Cited by 112
Functional loss of ARID1A is tightly associated with high PD‐L1 expression in gastric cancer
Kim, Y., Ahn, J. M., Bae, W. J., Sung, C. O., & Lee, D. (2019) · International Journal of Cancer · doi:10.1002/ijc.32140 · Cited by 113
High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features
Liu, X., Choi, M. G., Kim, K., Kim, K., Kim, S. T., Park, S. H., Cristescu, R., Peter, S. A., & Lee, J. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152881 · Cited by 127
Chen, Z., Chen, Y., Sun, Y., Tang, L., Zhang, L., Hu, Y., He, M., Li, Z., Cheng, S., Yuan, J., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01932-y · Cited by 137
The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
Tsang, C. M., & Tsao, S. W. (2015) · Virologica Sinica · doi:10.1007/s12250-015-3592-5 · Cited by 120
signeR: an empirical Bayesian approach to mutational signature discovery
Rosales, R. A., Drummond, R. D., Valieris, R., Dias-Neto, E., & da Silva, I. T. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw572 · Cited by 112
Viral sequences in human cancer
Cantalupo, P. G., Katz, J. P., & Pipas, J. M. (2018) · Virology · doi:10.1016/j.virol.2017.10.017 · Cited by 111
Gastric Parietal Cell Physiology and Helicobacter pylori–Induced Disease
Yao, X., & Smolka, A. J. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.02.036 · Cited by 129
Perioperative chemotherapy for resectable gastric cancer: MAGIC and beyond
Choi, A. H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i24.7343 · Cited by 112
Probing the O-Glycoproteome of Gastric Cancer Cell Lines for Biomarker Discovery*
Campos, D., Freitas, D. P., Gomes, J., Magalhães, A., Steentoft, C., Gomes, C., Vester-Christensen, M. B., Ferreira, J. A., Afonso, L. P., Santos, L. L., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.046862 · Cited by 119
Epstein–Barr Virus: Diseases Linked to Infection and Transformation
Jha, H. C., Pei, Y., & Robertson, E. S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01602 · Cited by 124
Epigenetic regulation of AURKA by miR-4715-3p in upper gastrointestinal cancers
Gomaa, A. R., Peng, D., Chen, Z., Soutto, M., Abouelezz, K., Corvalán, A. H., & El-Rifai, W. M. (2019) · Scientific Reports · doi:10.1038/s41598-019-53174-6 · Cited by 116
Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer
McGrail, D. J., Garnett, J., Yin, J., Dai, H., Shih, D. J. H., Lam, T., Li, Y., Sun, C., Li, Y., Schmandt, R. E., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.01.011 · Cited by 120
“, 2012), and 20% of gastric cancers (Bass et al., 2014).”
BackgroundHuang, Y.-H., Zhang, C. Z., Huang, Q., Yeong, J. P.-S., Wang, F., Yang, X., He, Y., Zhang, X., Zhang, H., Chen, S.-L., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.037 · Cited by 114
Ma, S.-D., Xu, X., Jones, R., Delecluse, H., Zumwalde, N. A., Sharma, A., Gumperz, J. E., & Kenney, S. C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005642 · Cited by 112
TCGA Expedition: A Data Acquisition and Management System for TCGA Data
Chandran, U. R., Medvedeva, O. P., Barmada, M. M., Blood, P. D., Chakka, A. B., Luthra, S., Ferreira, A. M., Wong, K. F., Lee, A. V., Zhang, Z., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165395 · Cited by 117
Xu, T., Ma, P., Wang, W., Shuai, Y., Wang, Y., Yu, T., Xia, R., & Shu, Y. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-018-0236-y · Cited by 117
Chen, C., Zhang, F., Zhou, N., Gu, Y., Zhang, Y., He, Y.-D., Wang, L., Yang, L., Zhao, Y., & Li, Y. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1581547 · Cited by 113
Seidlitz, T., Chen, Y., Uhlemann, H., Schölch, S., Kochall, S., Merker, S. R., Klimová, A., Hennig, A., Schweitzer, C., Pape, K., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.09.026 · Cited by 120
Regulation of PD-L1 expression in cancer and clinical implications in immunotherapy.
Ju, X., Zhang, H., Zhou, Z., & Wang, Q. (2020) · PubMed · Cited by 133
Li, Z., Gao, X., Peng, X., Chen, M.-J. M., Li, Z., Wei, B., Wen, X., Wei, B., Dong, Y., Bu, Z., et al. (2020) · Science Advances · doi:10.1126/sciadv.aay4211 · Cited by 127
Metadata
- Authors
- The Cancer Genome Atlas Research Network
- Venue
- Nature
- Published
- 2014-07-23
- Volume
- 513
- Issue
- 7517
- Pages
- 202-209
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4170219
- OpenAlex
- W2126547130
- Cited by
- 6,498
- References
- 43
- Citations by year
- 2026: 455 · 2025: 481 · 2024: 569 · 2023: 637 · 2022: 620 · 2021: 737 · 2020: 653 · 2019: 554 · 2018: 560 · 2017: 490 · 2016: 398 · 2015: 297 · 2014: 41
- FWCI
- 327.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- KUMeL Repository (Keimyung University) (submittedVersion, cc-by-nc-nd)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health
- National Human Genome Research Institute (U54HG003067, R01HG007069, U54HG003079, U54HG003273, R01HG005690)
- National Cancer Institute (P30CA16672, K08CA134931, P50CA098258, U24CA143882, P01CA028842, R01CA180006, U24CA143843, U24CA143840, U24CA143858, U24CA126543, U24CA144025, U24CA143866, U24CA143883, U24CA143845, U24CA180951, U24CA143867, U24CA143848, U24CA143799, U24CA143835, K99CA166729, P30CA008748, P30CA016672, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Keywords
- gastric adenocarcinoma, molecular classification, Epstein-Barr virus, PIK3CA mutation, DNA hypermethylation, PD-L1, PD-L2, microsatellite instability, chromosomal instability, genome stability, RHOA mutations, aneuploidy, targeted therapy, patient stratification
- MeSH terms
- Adenocarcinoma, Herpesvirus 4, Human, Female, Humans, Male, Mutation, Stomach Neoplasms, Genome, Human, Gene Expression Regulation, Neoplastic, Proteome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.